← Latest Filings
D
Davidson Michael H.
Chief Executive Officer
Open-market buys
1
$227K total
Open-market sells
8
$25.3M total
Tracking since
Feb 2026
Activity timeline
Open-market buy — $227K
NewAmsterdam Pharma Co N.V. · Sep 14, 2026
Open-market sale — $14.8M
NewAmsterdam Pharma Co N.V. · Mar 2, 2026
Open-market trades from the last two years.
Holdings as last reported
364,000 Option (right to buy) in NAMS
Held directly · as of 2026-01-07
285,715 Ordinary Shares in NAMS
Held indirectly (See footnote) · as of 2026-09-14
Companies touched
NewAmsterdam Pharma Co N.V.
CIK 0001936258
TENAX THERAPEUTICS, INC.
CIK 0000034956
